Delirium, Dementia, Amnestic, Cognitive Disorders  >>  sembragiline (RO4602522)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sembragiline (RO4602522) / Roche, Evotec
MAyflOwer RoAD, NCT01677754 / 2012-000943-29: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Completed
2
542
US, Canada, Europe, RoW
RO4602522, Placebo, Donepezil, Memantine, Rivastigmine, Galantamine
Hoffmann-La Roche
Alzheimer's Disease
06/15
06/15

Download Options